T
BSX icon

Tidemark’s Boston Scientific BSX Stock Holding History

Tidemark’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2K Sell
28
-30
-52% -$1.63K ﹤0.01% 727
2026
Q1 		$3.64K Hold
58
– – ﹤0.01% 591
2025
Q4 		$5.53K Hold
58
– – ﹤0.01% 488
2025
Q3 		$5.66K Hold
58
– – ﹤0.01% 512
2025
Q2 		$6.23K Hold
58
– – ﹤0.01% 495
2025
Q1 		$5.85K Hold
58
– – ﹤0.01% 498
2024
Q4 		$5.18K Buy
+58
New +$5.11K ﹤0.01% 502

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Tidemark's BSX Position: Q2 2026 in Review

Tidemark reduced its Boston Scientific (BSX) stake by 52% in Q2 2026, selling an estimated $1.63K and leaving 28 shares worth $1.2K. The position accounts for ﹤0.01% of the portfolio, ranked #727.

Tidemark first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.23K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Tidemark held 28 shares of Boston Scientific worth $1.2K as of Q2 2026.
  • Tidemark sold 30 Boston Scientific shares in Q2 2026, an estimated $1.63K.
  • Boston Scientific made up ﹤0.01% of Tidemark's portfolio in Q2 2026, its #727 holding.
  • Tidemark first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • Tidemark's Boston Scientific position peaked at $6.23K in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Tidemark's 13F filing for Q2 2026, filed 10 Aug 2026.